Evidence map›Paper›PMID 40162151›Full record

ArticleOxford medical case reports2025

Aase-Smith syndrome type 2 with new neurological findings.

Sarah Aljarad, Ahmad Alhamid, Hamdah Hanifa, Obada Zayegh, Jamal Ataya, Ziad Aljarad

Abstract readCase Reports
In one paragraph

Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah AljaradDepartment of haematology, Damascus University Faculty of Medicine,  Damascus, Syria.
Ahmad AlhamidBiomedical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hamdah HanifaFaculty of Medicine, University of Kalamoon, Al-Nabk, Syria.ORCID https://orcid.org/0000-0003-2970-7379
Obada ZayeghHealthcare, Royal Devon University Healthcare NHS Foundation Trust, Exeter, DE, United Kingdom.
Jamal AtayaMedicine, University of Aleppo Faculty of Medicine, Aleppo, Syria.ORCID https://orcid.org/0000-0003-4848-6719
Ziad AljaradDepartment of Gastroenterology, University of Aleppo, Aleppo, Syria.ORCID https://orcid.org/0000-0002-3422-5780

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aase-Smith syndrome type 2 is a rare genetic disorder that affects erythropoiesis and bone development, causing hypoplastic anemia and abnormalities in the fingers and toes, specifically triphalangeal thumbs. While there is no cure, treatment involves managing symptoms through blood transfusions, surgical intervention, and genetic counselling. A 15-year-old student presented with an unmeasured fever for two months, recurrent lung infections, difficulty in speech, and impaired gait. The patient had multiple congenital malformations including triphalangeal thumbs and a history of mild anemia. Bone marrow biopsy revealed an isolated slowing of erythroid lineage maturation. Radiology studies showed scoliosis, hand deformities, and multiple calcified lesions in the brain. The patient's fever exacerbated, and oxygen saturation deteriorated, necessitating tracheal intubation. Several hours later, the patient passed away.

Indexed as

Aase-Smith syndrome type 2case reportgenetic disorderneurological findingsnew findings

Identifiers

PMID40162151
PMCPMC11952885

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.